Nuriplan Co., Ltd. (KOSDAQ:069140)
1,646.00
+118.00 (7.72%)
At close: Jun 29, 2026
Nuriplan Revenue
Nuriplan had revenue of 27.22B KRW in the quarter ending March 31, 2026, with 16.09% growth. This brings the company's revenue in the last twelve months to 121.41B, up 12.47% year-over-year. In the year 2025, Nuriplan had annual revenue of 117.64B with 1.36% growth.
Revenue (ttm)
121.41B
Revenue Growth
+12.47%
P/S Ratio
0.20
Revenue / Employee
2.48B
Employees
49
Market Cap
24.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 117.64B | 1.58B | 1.36% |
| Dec 31, 2024 | 116.06B | -6.12B | -5.01% |
| Dec 31, 2023 | 122.18B | -8.97B | -6.84% |
| Dec 31, 2022 | 131.15B | -1.64B | -1.24% |
| Dec 31, 2021 | 132.80B | -6.56B | -4.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Saedong | 200.17B |
| CAS Corporation | 159.83B |
| Mirae Asset Vision Special Purpose Acquisition 2 Company | 104.86B |
| Point Mobile | 92.71B |
| Yulchon | 79.24B |
| KODI CO., LTD | 73.31B |
| ChoA Pharmaceutical Co., LTD. | 59.62B |
| Shindo Eng. Lab. | 32.63B |